- Home
- RAYA vs COEP Comparison
RAYA vs COEP Comparison
Compare RAYA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- COEP
- Stock Information
- Founded
- RAYA 2019
- COEP 2017
- Country
- RAYA China
- COEP United States
- Employees
- RAYA N/A
- COEP N/A
- Industry
- RAYA Metal Fabrications
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RAYA Consumer Discretionary
- COEP Health Care
- Exchange
- RAYA Nasdaq
- COEP Nasdaq
- Market Cap
- RAYA 103.6M
- COEP 27.4M
- IPO Year
- RAYA 2022
- COEP N/A
- Fundamental
- Price
- RAYA $2.53
- COEP $9.47
- Analyst Decision
- RAYA
- COEP
- Analyst Count
- RAYA 0
- COEP 0
- Target Price
- RAYA N/A
- COEP N/A
- AVG Volume (30 Days)
- RAYA 548.6K
- COEP 37.4K
- Earning Date
- RAYA 01-01-0001
- COEP 08-15-2025
- Dividend Yield
- RAYA N/A
- COEP N/A
- EPS Growth
- RAYA N/A
- COEP N/A
- EPS
- RAYA N/A
- COEP N/A
- Revenue
- RAYA $30,300,360.00
- COEP $62,874.00
- Revenue This Year
- RAYA $20.95
- COEP N/A
- Revenue Next Year
- RAYA N/A
- COEP N/A
- P/E Ratio
- RAYA N/A
- COEP N/A
- Revenue Growth
- RAYA 49.10
- COEP N/A
- 52 Week Low
- RAYA $0.56
- COEP $2.31
- 52 Week High
- RAYA $3.14
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- RAYA 58.42
- COEP 62.24
- Support Level
- RAYA $2.31
- COEP $7.25
- Resistance Level
- RAYA $2.99
- COEP $9.90
- Average True Range (ATR)
- RAYA 0.41
- COEP 0.63
- MACD
- RAYA 0.01
- COEP 0.26
- Stochastic Oscillator
- RAYA 58.50
- COEP 85.62
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.